^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
KD-496
i
Other names: KD-496, NKG2D/CLDN18.2 CAR-T
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
KAEDI
Drug class:
CLDN18.2-targeted CAR-T immunotherapy, NKG2D-targeted CAR-T immunotherapy
Related drugs:
